| Primary information |
|---|
| ID | antitb_1904 |
| Peptide Name | Bovine lactoferricin 17-30 |
| Sequence | FKCRRWQWRMKKLG |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Length | 14 |
| Chirality | L |
| Nature | Cationic |
| Source | Natural |
| Origin | Derived from bovine lactoferricin protein |
| Species | Mycobacterium avium |
| Strain | Mycobacterium avium 2-151 smD |
| Inhibition Concentartion | IC50 = 12.4± 0.3 μM |
| In vitro/In vivo | In vitro |
| Cell Line | NA |
| Inhibition Concentartion | Tratment with this concentration inhibit 50% bacterial growth |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | Lipid bilayer |
| Combination Therapy | NA |
| Other Activities | NA |
| Pubmed ID | 24709266 |
| Year of Publication | 2014 |
| 3-D Structure | NA |